doi:10.3969/j.issn.1671-2587.2019.05.030

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (5): 552-557.DOI: 10.3969/j.issn.1671-2587.2019.05.030

Previous Articles Next Articles

Received:2018-11-16 Online:2019-10-20 Published:2019-10-29

1 Delbos F,Bertrand G,Croisille L,et al. Fetal and neonatal alloimmune thrombocytopenia:predictive factors of intracranial hemorrhage[J]. Transfusion,2016,56(1):59-66,58.
2 石晶,贾苍松. 新生儿同种免疫性血小板减少症的诊治[J]. 中国实用儿科杂志,2014,29(7):506-508.
3 Kumpel B M,Sibley K,Jackson D J,et al. Ultrastructural localization of glycoprotein IIIa(GPIIIa,β3 integrin)on placental syncytiotrophoblast microvilli:implications for platelet alloimmunization during pregnancy[J]. Transfusion,2008,48(10):2077-2086.
4 Kumpel B M,Manoussaka M S. Placental immunology and maternal alloimmune responses[J]. Vox Sang,2012,102(1):2-12.
5 Curtis B R,Mcfarland J G. Human platelet antigens - 2013[J]. Vox Sang,2014,106(2):93-102.
6 Feng M L,Liu D Z,Shen W,et al. Establishment of an HPA-1- to -16-typed platelet donor registry in China[J]. Transfus Med,2006,16(5):369-374.
7 张毅,于媛,乔文本,等. 山东汉族人群HPA1~16和HLA-A、B的群体遗传学研究[J]. 中华医学遗传学杂志,2016,33(5):690-693.
8 Nie Y M,Zhou H J,Fu Y S,et al. The allele frequencies of HPA 1-16 determined by PCR-SSP in Chinese Cantonese donors[J]. Transfus Med,2010,20(6):376-382.
9 Bhatti F A,Uddin M,Ahmed A,et al. Human platelet antigen polymorphisms (HPA-1,-2,-3,-4,-5 and -15)in major ethnic groups of Pakistan[J]. Transfus Med,2010,20(2):78-87.
10 Asmarinah,Dharma R,Ritchie N K,et al. Human platelet-specific antigen frequencies in Indonesian population[J]. Transfus Med,2013,23(4):250-253.
11 Tan J Y,Lian L H,Nadarajan V S. Genetic polymorphisms of human platelet antigens-1 to -6,and -15 in the Malaysian population[J]. Blood Transfus,2012,10(3):368-376.
12 Hauck-Dlimi B,Hammon K,Eckstein R,et al. Human platelet antigen genotypes in Turkish and Caucasian blood donors in Germany[J]. Tissue Antigens,2012,80(3):214-218.
13 Salem A H,Abdel H A,Abdalla E M,et al. Gene frequencies of human platelet alloantigens 1-5 in two Arab populations[J]. Blood Transfus Gene frequencies of human platelloantigens 1-5 in two Arab populations[J]. Blood Transfus,2014,12 Suppl 1:s281-s285.
14 Al-Ouda S K,Al-Banyan A A,Abdel G A,et al. Gene frequency of human platelet alloantigens-1 to -6 and -15 in Saudi blood donors[J]. Transfus Med,2016,26(3):220-224.
15 Curtis B R. Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia[J]. Br J Haematol,2015,171(5):671-682.
16 Ahlen M T,Husebekk A,Killie M K,et al. The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to MaternalABO Genotypes[J]. Clinical and Developmental Immunology,2012,2012:1-5.
17 Bonsetein L A N H N. Anti-HLA antibodies in neonatal alloimmune thrombocytopenia-Is there any clinical significance?[J]. Blood,2015,126(23):4647.
18 Wendel K,Akkok C A,Kutzsche S. Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies[J]. BMJ Case Rep,2017,2017:1-3.
19 邓晶,徐秀章,王嘉励,等. 与母源性HLA抗体相关的新生儿同种免疫性血小板减少症——附病例报告[J]. 中国输血杂志,2016,29(9):935-937.
20 Xu X,Liu Y,Hong X,et al. Variants of CD36 gene and their association with CD36 protein expression in platelets[J]. Blood Transfus,2014,12(4):557-564.
21 Xu X,Li L,Xia W,et al. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody[J]. International Journal of Hematology,2018,107(2):251-256.
22 Lin M,Xu X,Lee H L,et al. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines[J]. Transfusion,2018,58(1):189-195.
23 Sareban N,Macher S,Drexler C,et al. Platelet Antibody Analysis by Three Different Tests[J]. Journal of Clinical Laboratory Analysis,2015,29(3):198-202.
24 Rockenbauer L,Eichelberger B,Panzer S. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) andPak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodiesto detect platelloantibodies[J]. Clin Chem Lab Med,2015,53(11):1779-1783.
25 李睿书,凌冰,陆萍. HPA-1a、HPA-3a、HPA-5b抗体MAIPA定量检测方法的建立[J]. 检验医学,2018,33(1):50-54.
26 Heikal N M,Smock K J. Laboratory testing for platelet antibodies[J]. Am J Hematol,2013,88(9):818-821.
27 Sarkar R S,Philip J,Jain N. Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused Patients[J]. Indian Journal of Hematology and Blood Transfusion,2015,31(1):77-84.
28 Reesink C E H. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions,and the selection of compatible donors.[J]. Vox sanguinis,2003,84(1):73-88.
29 Buakaew J,Promwong C. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique:a comparative study in Thai patients[J]. Asian Pac J Allergy Immunol,2010,28(2-3):177-184.
30 Fujiwara K,Shimano K,Tanaka H,et al. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies[J]. Vox sanguinis,2009,96(3):244-251.
31 陶苏丹,刘瑛,和艳敏,等. 用体外表达的血小板膜蛋白GPⅢa偶联Luminex微球检测HPA-1a抗体[J]. 中华医学遗传学杂志,2017,34(1):40-44.
32 方代华,文成,邓罗华,等. 微柱凝胶技术在新生儿同种免疫性血小板减少症的应用[J]. 国际检验医学杂志,2015,36(6):770-771.
33 Winkelhorst D,Murphy M F,Greinacher A,et al. Antenatal management in fetal and neonatal alloimmune thrombocytopenia:a systematic review[J]. Blood,2017,129(11):1538-1547.
34 Rossi K Q,Lehman K J,O'Shaughnessy R W. Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle[J]. J Matern Fetal Neonatal Med,2016,29(11):1783-1788.
35 Zdravic D,Yougbare I,Vadasz B,et al. Fetal and neonatal alloimmune thrombocytopenia[J]. Semin Fetal Neonatal Med,2016,21(1):19-27.
36 Winkelhorst D,Oepkes D,Lopriore E. Fetal and neonatal alloimmune thrombocytopenia:evidence based antenatal and postnatal management strategies[J]. Expert Rev Hematol,2017,10(8):729-737.

[1]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 6-10.
[2]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 10-12.
[3]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 454-457.
[4]	TANG Zong-sheng. Strategies to Enhance the Care and Privacy of Plasma Donors during COVID-19 Rehabilitation and Their Significance [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 458-461.
[5]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 470-472.
[6]	LIU Li, MA Chun-ya, PAN Xue, et al.. Clinical Blood Use Characteristics in a Tertiary Hospital in Beijing on the Novel Coronavirous Pneumonia Outbreak [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 354-357.
[7]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 376-379.
[8]	LU Xiao-jun, ZHANG Li-bo, WANG Hui, et al.. The Practice and Retrospect of Nanjing Blood Donation Regulation Legislation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 394-397.
[9]	WANG Jin, QIU Yan, CUI Shuang, et al.. Application of Traceability Audit in Internal Audit Quality of Blood Collection and Supply Organization [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 405-407.
[10]	YAN Jun, YIN Wen, ZHANG Kan. Impact of SARS-CoV-2 on Blood Safety [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 232-235.
[11]	YE Sheng, SHEN Yan, CHEN Jin, et al. Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 241-245.
[12]	Chinese Society of Blood Transfusion Clinical Transfusion Management Committee. Investigation and Analysis of Biosafety Protection of Blood Transfusion Departments (Blood Banks) in 2 309 Hospitals during the Epidemic Situation of Novel Coronavirus Pneumonia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 249-252.
[13]	YING Shang-yun, ZHAO Yi-lun, YUAN Yong, et al. Strategies for the Prevention and Control of Emergency Group Blood Donation Sites during the COVID-19 Pandemic [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 253-258.
[14]	WANG Zheng-yang, SU Jian, CHEN Jiang-tian, et al. Analysis and Countermeasure Research on Performance Management of Blood Services in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 285-290.
[15]	CHEN Jiang-tian, YU Li, HAN Wen-juan, et al. The Dilemma and Countermeasures of Human Resource Allocation in Blood Collection and Supply Institutions [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 135-138.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact